Tolerability of the Triptans: Clinical Implications

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.2, 2003-01, pp. : 93-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Over-the-Counter Triptans for Migraine: What are the Implications?

By Tfelt-Hansen Peer

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 877-883

Adis International

Access to resources Recommend Favorite

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management

By Millson D.S. Tepper S.J. Rapoport A.M.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 391-404

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability

By Crouse John R

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 287-304

Informa Healthcare

Access to resources Recommend Favorite

Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety

By Kothare Sanjeev V Kaleyias Joseph

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 493-506

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide

By Lee Noel Wald Arnold

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 651-659

Informa Healthcare

Access to resources Recommend Favorite